A combination of Citrus reticulata peel and black tea inhibits migration and invasion of liver cancer via PI3K/AKT and MMPs signaling pathway

被引:21
作者
Wen, Shuai [1 ]
Sun, Lingli [2 ]
An, Ran [1 ]
Zhang, Wenji [2 ]
Xiang, Limin [2 ]
Li, Qiuhua [2 ]
Lai, Xingfei [2 ]
Huo, Mengen [1 ]
Li, Dongli [1 ,3 ]
Sun, Shili [2 ]
机构
[1] Wuyi Univ, Sch Biotechnol & Hlth Sci, Jiangmen 529020, Peoples R China
[2] Guangdong Acad Agr Sci, Tea Res Inst, Guangdong Key Lab Tea Resources Innovat & Utiliza, Guangzhou 510640, Guangdong, Peoples R China
[3] Int Healthcare Innovat Inst Jiangmen, Jiangmen 529040, Peoples R China
基金
芬兰科学院; 中国国家自然科学基金;
关键词
Citrus reticulate peel black tea; Liver cancer; Migration; Invasion; Signaling pathway; SYNERGISTIC ANTICANCER ACTIVITY; HEPATOCELLULAR-CARCINOMA CELLS; GREEN TEA; IN-VITRO; (-)-EPIGALLOCATECHIN GALLATE; ANTIOXIDANT ACTIVITY; DRUG-RESISTANCE; GROWTH; MECHANISMS; APOPTOSIS;
D O I
10.1007/s11033-019-05157-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liver cancer, one of the most common malignancies, is the second leading cause of cancer death in the world. The citrus reticulate peel and black tea have been studied for their beneficial health effects. In spite of the many studies have been reported, the underlying molecular mechanisms underlying its health benefits are still not fully understood. In present study, we developed a unique citrus reticulate peel black tea (CRPBT) by combined citrus reticulate peel and black tea and assessed its active ingredients, anti-oxidant and anti-liver cancer effects in vitro. The results suggested that CRPBT exhibited antioxidant capacity and effectively inhibited proliferation and migration of liver cancer cells in a dose- and time- dependent manner. Mechanistically, CRPBT significantly down-regulated phosphorylation of PI3K and AKT, and up-regulated the ratio of Bax/Bcl-2, and suppressed the expression of MMP2/9, N-cadherin and Vimetin proteins in liver cancer cells. Taken together, CRPBT has good effect on inhibiting migration, invasion, proliferation, and inducing apoptosis in liver cancer cells.
引用
收藏
页码:507 / 519
页数:13
相关论文
共 58 条
  • [1] Akuli A, 2012, I CONF SENS TECHNOL, P23, DOI 10.1109/ICSensT.2012.6461679
  • [2] [Anonymous], SCI REP UK
  • [3] The apoptotic effect of sarsasapogenin from Anemarrhena asphodeloides on HepG2 human hepatoma cells
    Bao, Wenna
    Pan, Haifeng
    Lu, Min
    Ni, Yuan
    Zhang, Rui
    Gong, Xingguo
    [J]. CELL BIOLOGY INTERNATIONAL, 2007, 31 (09) : 887 - 892
  • [4] Assessment of the cytotoxicity, antioxidant activity and chemical composition of extracts from the cyanobacterium Fischerella major Gomont
    Batsalova, Tsvetelina
    Basheva, Diyana
    Bardarov, Krum
    Bardarov, Ventzislav
    Dzhambazov, Balik
    Teneva, Ivanka
    [J]. CHEMOSPHERE, 2019, 218 : 93 - 103
  • [5] Tea and human health: biomedical functions of tea active components and current issues
    Chen, Zong-mao
    Lin, Zhi
    [J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2015, 16 (02): : 87 - 102
  • [6] Dhanasekaran Renumathy, 2016, F1000Res, V5, DOI 10.12688/f1000research.6946.1
  • [7] Compositional Variation among Black Tea Across Geographies and Their Potential Influence on Endothelial Nitric Oxide and Antioxidant Activity
    Dias, Paul Mark
    Changarath, Jayashree
    Damodaran, Anita
    Joshi, Manoj Kumar
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2014, 62 (28) : 6655 - 6668
  • [8] Polymethoxyflavones in peel of Citrus reticulata 'Chachi' and their biological activities
    Duan, Li
    Dou, Li-Li
    Yu, Ke-Yun
    Guo, Long
    Chen Bai-Zhong
    Li, Ping
    Liu, E-Hu
    [J]. FOOD CHEMISTRY, 2017, 234 : 254 - 261
  • [9] The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo
    Fang, Evandro Fei
    Zhang, Chris Zhi Yi
    Wong, Jack Ho
    Shen, Jia Yun
    Li, Chuan Hao
    Ng, Tzi Bun
    [J]. CANCER LETTERS, 2012, 324 (01) : 66 - 74
  • [10] Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate
    Fassina, G
    Venè, R
    Morini, M
    Minghelli, S
    Benelli, R
    Noonan, DM
    Albini, A
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (14) : 4865 - 4873